News & Analysis
- Data & Tools
- Login | Register
The Canadian company has secured another three years’ worth of income from an encumbered portfolio, while the buyers can take high-quality assets into new markets
03 February 2022
New entity can now begin monetising a horde of around 35,000 assets that is already licensed to many major players in the mobile space
31 January 2022
After so many delays in finalising the transaction, the pressure is on the Canadian company to get it over the line
27 January 2022
The valuation of patent rights is not a straightforward matter. In Canada, the remedies available to patent owners are arguably the most important factor in determining value.
12 January 2022
“We are literally down to the last few important items now,” says company CEO John Chen on Q3 earnings call
22 December 2021
The company is due to release its Q3 financials tomorrow, but it is not known whether the touted sale of a portfolio of well over 30,000 individual assets will also be announced
20 December 2021
In this Q&A, three Gowlings WLG professionals provide practical advice from a local law perspective for IP transactions in three jurisdictions: Canada, China and the United Kingdom.
15 December 2021
The judgment of the US Supreme Court in Minerva Surgical, Inc v Hologic, Inc regarding the limitations of the doctrine of assignor estoppel sheds light on best practices for transactions and due diligence.
08 December 2021
San Jose company transfers semiconductor rights to an affiliate of the Canadian NPE that's litigating against Micron
17 November 2021
In the wake of the firm’s latest $250 million investment, Sagard Healthcare Royalty Partners’ Ali Alagheband gives the inside track on life sciences IP-backed revenue sales
01 November 2021
Unlock unlimited access to all IAM content